Keros Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $14M | 358k | 39.76 |
| 2023-09-30 | $401k | 13k | 31.88 |
| 2023-06-30 | $3.3M | 83k | 40.18 |
| 2023-03-31 | $3.7M | 87k | 42.70 |
| 2022-12-31 | $550k | 12k | 48.02 |
| 2022-09-30 | $301k | 8.0k | 37.43 |
| 2022-06-30 | $293k | 10k | 28.52 |
| 2022-03-31 | $560k | 10k | 55.26 |
| 2021-12-31 | $646k | 11k | 58.00 |
| 2021-09-30 | $436k | 11k | 40.42 |
| 2021-06-30 | $467k | 11k | 42.18 |
| 2021-03-31 | $588k | 9.7k | 60.93 |
| 2020-12-31 | $730k | 10k | 69.89 |
| 2020-09-30 | $150k | 3.9k | 38.84 |
| 2020-06-30 | $137k | 3.5k | 38.84 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft